Market and competitive intelligence are at the core of our strategy practice.

We leverage industry-specific datasets to support data-driven findings and recommendations to support your project. Our capabilities include:

Therapeutic Landscape Mapping
Comprehensive assessment of disease areas to identify emerging trends, white spaces, and evolving standards of care. Analyses integrate trial registries, conference data, publications, and investor reports to highlight scientific, clinical, and commercial dynamics shaping the competitive field.

Pipeline and Asset Benchmarking
Systematic profiling of competitor assets by mechanism, target, trial design, and differentiation strategy. We leverage primary and secondary data to identify positioning opportunities and potential threats across development phases.

KOL and Market Signal Analysis
Integration of key opinion leader insights, conference sentiment, and partnership activity to uncover early signals of market movement. This enables clients to anticipate shifts in development focus or investment appetite.

Partnering and BD Intelligence
Identification and qualification of potential partners or acquisition targets based on therapeutic fit, development maturity, and strategic alignment. Our intelligence supports both buy-side diligence and out-licensing initiatives.

Ongoing Competitive Monitoring
Continuous tracking of competitor updates, regulatory milestones, and clinical data readouts, presented through concise, action-oriented deliverables tailored to executive decision-making needs.

Strategic Synthesis and Advisory
We don’t just deliver data—we contextualize it. Our analyses conclude with strategic implications, helping clients translate intelligence into actionable priorities across R&D, business development, and corporate strategy.